Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2.
Res Sq. 2022 Feb 24:rs.3.rs-1375091. doi: 10.21203/rs.3.rs-1375091/v1. Preprint.
Res Sq. 2022.
PMID: 35233565
Free PMC article.
Updated.